DANNIELLE MASTROIANNI: Open Payments
NPI 1760188825 · CHARDON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$984 in 35 payments from 8 companies in 2025. Trend: 2023 $386 · 2024 $2,325 · 2025 $984
Food & beverage: $984
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $439 |
| UCB, Inc. | 6 | $172 |
| Merz Pharmaceuticals, LLC | 1 | $125 |
| Alexion Pharmaceuticals, Inc. | 4 | $109 |
| AstraZeneca Pharmaceuticals LP | 3 | $63 |
| ARGENX US, INC. | 1 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: UBRELVY, QULIPTA, INBRIJA, ULTOMIRIS, Briviact, WAINUA, Zilbrysq, Rystiggo.
Industry payments across OH — which companies pay providers there.
